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Samuel Agyenim Boateng, RN, BSN, FNP Student
Otterbein University, Westerville, Ohio
Introduction
Cardiovascular disease (CAD) is the
most common cause of death for men
and women in the US. The disease has
been extensively studied in males
(Gulati & Bairey Merz, 2012, p. 141).
CVD poses an obvious challenge to the
health of women. Coronary heart
disease (CHD) is described as a
"modern epidemic" (Banner, 2010, p.
3123). Although, the prevalence of CVD
has prompted many studies for
prevention and treatment, little is
known about CVD in women. It Is now
known that the mortality rates In
women have surpassed that of men.
Recent reports Indicate that CVD killed
more women in three decades than
men. In the US, 421, 31i women died
from the disease (strain-Strand et. al,
2011, p.459; Gulati & Bairey Merz,
2012, p. 141).

•

•

The population of men
and women with CVD is
expected to rise by 1.5 %
annually, as more men
and women seek
treatment for ischemic
pains and Infarction
(Sancho & del Carmen,
2011, p. 1463).
More women have died
from CVD and the
probability of a woman
to die from CVD has
increased more than
eight times. Women
remain less aware of the
unique symptoms of the
disease (Sjöström-Strand
et. al, 2011, p. 459).

Unique Presentation in Women
MI is associated with countless signs
and symptoms (s/s) and some specific
characteristics that frequently assist in
Identifying the underlying pathology

•

•

•

•

Atypical s/s in female
patients are fatigue,
sleep disturbance,
dyspnea and
diminished functional
capacity (Edwards,
2012, p. 575;
Coventry et al, 2013).
Classic chest pain that
characterized Ml in
men is quite unusual
in women.
50-60% first sign of
heart disease was
either acute MI or
sudden cardiac death.
The clinical outcomes
for women presenting
with chest discomfort
has always been
worse (Mieres et al,
2011, p.1266; Edwards,
2012, p. 575).

•

•

•

•

C/o chest pains in a
woman can best
serve as a predictor
adverse CVA event in
the absence
obstructive CAD.
Women c/o chest
pain while at rest &
lasts longer than
usual.
MI in women is
preceded by s/s of
back pain, arm,
shoulder, jaw, throat
pain and toothache.

Pathophysiology of MI
Generally, CHD has been considered as a disease characterized by the presence of lesions in
the surface of the tha arteries of the heart. However, numerous studies have revealed t the
pathological processes of CHD in women does not follow the previously established pattern
of the disease. Research studies have shown that women who undergo coronary
angiography studies for chest pains usually show no evidence of obstructive disease
(Edwards, 2012, p. 575; Gulati & Bairey Merz, 2012, p. 142). This was generally accepted that
the presence of "clear arteries" on diagnostic tests indicated low cardiac risk.
But recent studies have demonstrated that this conclusion does not hold true for female
patients. This has been substantiated by evidence from the Women's Ischemia Syndrome
Evaluation (WISE) studies stating that coronary microvascular dysfunction is present in over
50 percent of women without obstructive disease.
Obstructive disease or stenosis of the coronary arteries Is defined as occlusion of the vessel
of the lumen greater or equal 50 percent. These women had poorer outcome even in the
absence obstructive lesion. In addition to the above, it has also been noted that many of
these women demonstrated abnormal stress test results which could be indicative of
ischemia and or microvascular dysfunction (Edwards, 2012, p. 575; Gulati & Bairey Merz,
2012, p. 142).

Hormonal changes
experienced after
menopause plays a
critical role. Reduced
estrogen causes lipid
dysfunctions and
significantly increases
the incidence of MI
(Edwards 2012, p. 576;
Gulati & Bairey Merz,
2012, p. 142).

The chart below shows the proportion of male and female with CAD by age and
sex, 2007-2008 adapted from www.aihw.gov.au/cardiovascular-health/prevalence/

Significance
The literature provides substantive
insights into the pathophysiological
differences that exist between men
and women with myocardial
infarction. It is now known from
postmortem studies that women
manifest coronary plaque erosion
and distal embolization (Gulati &
Bairey Merz, 2012, p. 144). The
evidence indicates the presence of
small artery disease that is
manifested in retinal artery
occlusion that is found In women
with heart disease (Gulati & Bairey
Merz, 2012, p. 144). The data
indicates that the typical cardiac risk
factors including increased lipids,
diabetes and HTN greatly
compromise endothelial response
after menopause and endothelial
dysfunction contributes to MI in
women (Gulati & Bairey Merz, 2012,
p. 144).

Implications
The relevance of the pathological process
Is of vital significance to health
professionals in number of ways.
First, the knowledge gleaned from the
research must be utilized to achieve the
primary objective of health promotion
and disease prevention In area of
myocardial infarction in women.

The chart above indicates the mortality rate of Acute MI for both men and women adapted
from httplinccd.cdc.gov
Coronary microvascular disease is a disorder affecting the small coronary arteries of the
heart. These changes In the lumen of the arteries are not easily seen on coronary
angiography. The disease usually begins at a point of injury to the inner lining of the arterial
wall. Asa result, there is a progressive lesion where plaque is formed and is deposited within
the endothelium. Continued deposits of plaques can cause the lumen to spasm and
thrombus. An obstruction eventually develops in the vessel resulting in diminished blood to
the coronary arteries causing chest pain or discomfort. The vascular endothelium is the
cellular layer lining the blood vessel.
A dysfunction in this layer plays a significant role in the pathological process of the disease.
As a result of this dysfunction, there is decreased production of vasodilators such as nitric
oxide and increased production of the potent vasoconstrictors such as endothelin and
thromboxane (Edwards, 2012, p. 575). The net result is vessel occlusion and diminished
blood flow to the coronary arteries leading to the clinical presentation of ischemic chest
pains and eventually myocardial infarction.

This requires initiating a robust health
education and screening aimed at the
reducing the conspicuous modifiable risk
factor such as hypertension, dyslipidemia
and diabetes that remains very crucial to
disease prevention and treatment
outcome (Edwards, 2012, p. 577; WorrallCarter et al, 2011, p.533).
Furthermore, critical attention must be
given to the unique risk factors such as
alterations in hormones after menopause,
and endothelial functional capacity. The
research data has revealed that these
factors contribute more to understanding
the disease process than the previous
established factors.

Implications
This, coupled with continued
Investigation, will further enhance the
understanding of the pathophysiology
of myocardial infarction and
eventually lead to early detection,
diagnosis and better prognosis in
women (Edwards, 2012, p. 577).
Skillful and knowledgeable care plays a
significant role in decreasing morbidity
and mortality in myocardial Infarction,
the advance practice nurse with a
clear understanding of the
pathophysiological process can really
impact the outcome of those affected
with MI.

Conclusions
Numerous studies have revealed that the
pathological processes of CHD in women
does not follow the previously established
pattern of the disease. It was generally
accepted that myocardial infarction was
considered as a disease characterized by the
presence of lesions in the surface of the
arteries of the heart.
However,research studies has proven
otherwise. It Is now understood that women
who undergo coronary angiography studies
for chest pains usually shows no evidence of
obstructive disease (Edwards, 2012, p. 575).
The pathophysiological differences have
been attributed to a combination of varying
factors. Some of the plausibly factors include
endothelial dysfunction, hormonal changes
after menopause, higher incidence of
modifiable risk factors for the disease. The
evidence points out that the majority of the
risk factors are modifiable which is vital to
disease prevention and treatment.
Additionally, there is the need for genderspecific education for health professionals as
well as Increased awareness among women.
Last but not the least, the data advocates for
more gender-specific and clinical programs
geared towards a comprehensive
methodology in myocardial studies In
women. This is essential to understanding
the unique symptom presentation in women.
The research outcome demonstrate genderspecific and sex differences in other to
eliminate the obstacles that have kept
women out. More research Is needed in this
area to improve the quality of life and health
outcomes for women (Wassail-Carter et al,
2011, p.533; Mieres et. al, 2011, p.1266).
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